Impaired endothelial-dependent forearm vascular relaxation in black Americans

Clinical Pharmacology and Therapeutics

Volumn 65, Issue 4, 1999, Pages 408-412

  Jones, Drew S ^b   Andrawis, Nabil S ^b   Abernethy, Darrell R ^a  

^a Division of Clinical Pharmacology   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN; NITROPRUSSIDE SODIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SENSITIVITY; FEMALE; FOREARM BLOOD FLOW; HUMAN; HYPERTENSION; INCIDENCE; MALE; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY;

EID: 0033014742     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(99)70135-9     Document Type: Article

References (30)

1. 1. Ganguli MC, Grimm RH Jr, Svendsen KH, Flack JM, Grandits GA, Elmer PJ. Higher education and income are related to a better Na:K ratio in blacks: baseline results of the Treatment of Mild Hypertension Study (TOMHS) data. Am J Hypertens 1997;10:979-84.
2. 2. Kaplan NM. Ethnic aspects of hypertension. Lancet 1994;344:450-2.
3. 3. Gillum RF. Pathophysiology of hypertension in blacks and whites: a review of the basis of racial blood pressure differences. Hypertension 1979;1:468-75.
4. 4. Miyoshi A, Suzuki H, Fujiwara M, Masai M, Iwasaki T. Impairment of endothelial function in salt-sensitive hypertension in humans. Am J Hypertens 1997;10:1083-90.
5. 5. Bloem LJ, Foroud TM, Ambrosius WT, Hanna MP, Tewksbury DA, Pratt JH. Association of the angiotensinogen gene to serum angiotensinogen in blacks and whites. Hypertension 1997;29:1078-82.
6. 6. Bloem LJ, Manatunga AK, Pratt JH. Racial difference in the relationship of an angiotensin I - converting enzyme gene polymorphism to serum angiotensin I - converting enzyme activity. Hypertension 1996;27:62-6.
7. 7. Caulfield M, Lavender P, Newell-Price J, Farrall M, Kamdar S, Daniel H, et al. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest 1995;96:687-92.
8. 8. Chiang FT, Hsu KL, Tseng CD, Hsiao WH, Lo HM, Chern TH, et al. Molecular variant M235T of the angiotensinogen gene is associated with essential hypertension in Taiwanese. J Hypertens 1997;15:607-11.
9. 9. Lang CC, Stein CM, Brown RM, Deegan R, Nelson R, He HB, et al. Attenuation of isoproterenol-mediated vasodilatation in blacks. N Engl J Med 1995;333:155-60.
10. 10. Stein CM, Deegan R, Wood AJ. Lack of correlation between arterial and venous beta-adrenergic receptor sensitivity. Hypertension 1997;29:1273-7.
11. 11. Johnson JA, Burlew BS, Stiles RN. Racial differences in beta-adrenoceptor - mediated responsiveness, J Cardiovasc Pharmacol 1995;25:90-6.
12. G-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens 1992;10:1025-31.
13. 13. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-6.
14. 14. Furchgott RF. Role of endothelium in responses of vascular smooth muscle. Circ Res 1983;53:557-73.
15. 15. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-7.
16. 16. Panza JA, Casino PR, Badar DM, Quyyumi AA. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation 1993;87:1475-81.
17. 17. Cockcroft JR, Chowienczyk PJ, Benjamin N, Ritter JM. Preserved endothelium-dependent vasodilatation in patients with essential hypertension. N Engl J Med 1994; 330:1036-40.
18. 18. Andrawis NS, Craft N, Abernethy DR. Calcium antagonists block angiotensin II-mediated vasoconstriction in humans: comparison with their effect on phenylephrine-induced vasoconstriction. J Pharmacol Exp Ther 1992; 261:879-84.
19. 19. Andrawis NS, Gilligan J, Abernethy DR. Endothelin-I - mediated vasoconstriction: specific blockade by verapamil. Clin Pharmacol Ther 1992;52:583-9.
20. 1-adrenergic blockade by verapamil. Clin Pharmacol Ther 1990;47:755-9.
21. 21. Whitney RJ. The measurement of volume changes in human limbs. J Physiol (Lond) 1953;121:1-27.
22. 22. Hokanson DE, Sumner DS, Strandness DE Jr. An electrically calibrated plethysmograph for direct measurement of limb blood flow. IEEE Trans Biomed Eng 1975;22:25-9.
23. 23. Holford NH, Sheiner LB. Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet 1981;6: 429-53.
24. 24. Stein CM, Lang CC, Nelson R, Brown M, Wood AJ. Vasodilation in black Americans: attenuated nitric oxide - mediated responses. Clin Pharmacol Ther 1997;62:436-43.
25. 25. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation 1993;88:2541-7.
26. 26. Lieberman EH, Gerhard MD, Uehata A, Walsh BW, Selwyn AP, Ganz P, et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 1994;121:936-41.
27. 27. Gerhard M, Roddy MA, Creager SJ, Creager MA. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension 1996;27:849-53.
28. 28. Bassett DR Jr, Duey WJ, Walker AJ, Howley ET, Bond V. Racial differences in maximal vasodilatory capacity of forearm resistance vessels in normotensive young adults. Am J Hypertens 1992;5:781-6.
29. 29. Hinderliter AL, Sager AR, Sherwood A, Light KC, Girdler SS, Willis PWT. Ethnic differences in forearm vasodilator capacity. Am J Cardiol 1996;78:208-11.
30. 2-adrenoceptor. Hypertension 1997;30:773-6.